Healthy subjects
Conditions
Interventions
Administration of aripiprazole PET, MRI, Neuropsychological test
Sponsors
National Institute of Radiological Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Healthy subjects who have the ability to provide informed consent
Exclusion criteria
Exclusion criteria: -Psychiatric disorders including drug dependence -Serious medical illness
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dopamine synthesis rate | — |
Countries
Japan
Outcome results
None listed